Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Baxter
Dow
Covington
UBS
Boehringer Ingelheim
Medtronic
Cantor Fitzgerald
Federal Trade Commission
US Army

Generated: October 22, 2017

DrugPatentWatch Database Preview

Fluocinolone acetonide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for fluocinolone acetonide and what is the scope of fluocinolone acetonide patent protection?

Fluocinolone acetonide
is the generic ingredient in thirteen branded drugs marketed by Allergan Herbert, Galderma Labs Lp, Taro, Akorn, Pharmafair, Identi Pharms Inc, Perrigo New York, Morton Grove, Gavis Pharms Llc, Alimera Sciences Inc, G And W Labs, Bausch And Lomb, G And W Labs Inc, Usl Pharma, Pharmaderm, Perrigo Israel, Hill Dermac, Alpharma Us Pharms, Medimetriks Pharms, Fougera Pharms Inc, Savage Labs, Lyne, and Actavis Labs Ut Inc, and is included in sixty-five NDAs. There are nine patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Fluocinolone acetonide has one hundred and eighty-three patent family members in twenty-six countries and one supplementary protection certificate in one country.

There are twelve drug master file entries for fluocinolone acetonide. Twenty-two suppliers are listed for this compound.

Summary for Generic Name: fluocinolone acetonide

US Patents:9
Tradenames:13
Applicants:23
NDAs:65
Drug Master File Entries: see list12
Suppliers / Packagers: see list22
Bulk Api Vendors: see list42
Clinical Trials: see list151
Patent Applications: see list4,655
Therapeutic Class:Otic Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:fluocinolone acetonide at DailyMed

Pharmacology for Ingredient: fluocinolone acetonide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmaderm
FLUOCINOLONE ACETONIDE
fluocinolone acetonide
CREAM;TOPICAL088045-001Dec 16, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
G And W Labs Inc
FLUOCINOLONE ACETONIDE
fluocinolone acetonide
SOLUTION;TOPICAL207441-001Sep 28, 2016ATRXNoNo► Subscribe► Subscribe► Subscribe
Morton Grove
FLUOCINOLONE ACETONIDE
fluocinolone acetonide
SOLUTION;TOPICAL088312-001Jan 27, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Alpharma Us Pharms
FLUOCINOLONE ACETONIDE
fluocinolone acetonide
SOLUTION;TOPICAL087159-001Jun 16, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Medimetriks Pharms
SYNALAR
fluocinolone acetonide
SOLUTION;TOPICAL015296-001Approved Prior to Jan 1, 1982ATRXYesYes► Subscribe► Subscribe► Subscribe
Lyne
FLUOCINOLONE ACETONIDE
fluocinolone acetonide
OIL;TOPICAL090982-001Apr 25, 2016ATRXNoNo► Subscribe► Subscribe► Subscribe
Pharmaderm
FLUOCINOLONE ACETONIDE
fluocinolone acetonide
SOLUTION;TOPICAL088048-001Dec 16, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Usl Pharma
FLUOCINOLONE ACETONIDE
fluocinolone acetonide
CREAM;TOPICAL088756-001Mar 28, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Akorn
FLUOCINOLONE ACETONIDE
fluocinolone acetonide
OIL/DROPS;OTIC202705-001Sep 9, 2016ATRXNoNo► Subscribe► Subscribe► Subscribe
Identi Pharms Inc
FLUOCINOLONE ACETONIDE
fluocinolone acetonide
OIL;TOPICAL201759-001Oct 17, 2011ATRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: fluocinolone acetonide

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,192,579Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof► Subscribe
7,439,249Inhibitors of phosphatases► Subscribe
8,574,659Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof► Subscribe
8,815,284Bioerodible sustained release drug delivery systems► Subscribe
9,566,336In situ gelling drug delivery system► Subscribe
8,574,613Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: fluocinolone acetonide

Country Document Number Estimated Expiration
Japan5661226► Subscribe
World Intellectual Property Organization (WIPO)2005000268► Subscribe
European Patent Office2233112► Subscribe
Austria409023► Subscribe
Argentina042920► Subscribe
China101862455► Subscribe
India4939DEN2012► Subscribe
Slovenia2233112► Subscribe
World Intellectual Property Organization (WIPO)2004043435► Subscribe
World Intellectual Property Organization (WIPO)0056340► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: FLUOCINOLONE ACETONIDE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2014000063Germany► SubscribePRODUCT NAME: FLUOCINOLONACETONID; NAT. REGISTRATION NO/DATE: 82809.00.00 20120720; FIRST REGISTRATION: GB PL 27813/0001 20120504
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
QuintilesIMS
Julphar
US Department of Justice
Healthtrust
Chinese Patent Office
Deloitte
Novartis
Covington
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot